TR
Trevena, Inc.
TRVN · OTC
$0.01 +0.00% (+$0.00)
1M +1,020.00%
Market Cap $9.67K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.00x
P/E N/A
EV/EBITDA N/A
Growth
23 /100
Declining Rev. growth 0.60%
EPS growth N/A
FCF growth N/A
Profitability
19 /100
Weak Gross margin 46.56%
Net margin 1,289.25%
FCF margin 1,058.43%
Quality
1 /100
Poor ROIC 104.42%
ROA 99.22%
Asset turnover 0.08x
Debt
100 /100
Low Current ratio 4.66x
Debt/Equity N/A
Int. coverage N/A
Stability
25 /100
Unstable Beta -0.41x
Rev. volatility 564.93%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o TRVN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Carrie L. Bourdow
Employees
23
Headquarters
Chesterbrook
Nadchodzące wydarzenia
05 LIS
Earnings
Upcoming earnings report